Current Events

25th Pharmacovigilance 2021
“Latest developments in pharmacovigilance, drug safety & risk management”
22nd - 23rd September 2021, Virtual Conference (Time Zone - EST)
After the successful journey of a series of 24 Pharmacovigilance conferences, Virtue Insight is proud to announce its 25th Pharmacovigilance 2021. We have been delivering the conference through close collaboration with the industry leaders for more than a decade. For the 2021 edition, the agenda includes a host of new and exciting features. Take a chance and make it count by attending this conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level.
DELEGATE REGISTRATION:
Email - kavitha@virtueinsight.co.in or TEL: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
EARLY BIRD PRICE (Valid Till 16th August 2021 - Not Valid for UK based attendees):
1 Delegate @ £399
3 Delegates @ £999
EARLY BIRD PRICE (Valid Till 16th August 2021 – For UK based attendees):
1 Delegate @ £399+VAT
3 Delegates @ £999+VAT
STANDARD PRICE (Valid From 17th August 2021 - Not Valid for UK based attendees)
1 Delegate @ £599
3 Delegates @ £1299
STANDARD PRICE (Valid From 17th August 2021 - For UK based attendees)
1 Delegate @ £599+VAT
3 Delegates @ £1299+VAT
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• MIRZA I. RAHMAN, Senior VP & Chief Global PV Officer, Otsuka Pharmaceutical Development & Commercialization
• JULIE GIROD, Vice President, Global Head of Case Management & Medical Evaluation, Sanofi-Aventis
• CARMIT STRAUSS, Global Safety Director (Benefit Risk Management Officer), Amgen
• WILLIAM WANG, Executive Director, Clinical Safety Statistics, Merck
• JUDY LI, Senior Director, Biostatistics Lead, San Diego Site, Bristol-Myers Squibb
• MELVIN MUNSAKA, Senior Director, Head Safety Statistics, Abbvie
• ARVIND BELLUR, Associate Vice President, Sanofi
• ROSALINA DOMIN, Senior Director, QA and Deviation Management Head PV Quality, Sanofi
• KHAUDEJA BANO, Executive Medical Director, Combination Product Safety Head, Amgen
• SHAUN COMFORT, Associate Director and Senior Safety Science Leader, Roche - Genentech
• GIGI ATALLA, Vice President, Head of Global Drug Safety & Pharmacovigilance, Genmab
• MIRCEA CIUCA, Global Therapeutic Area Head - Global Clinical Safety & PV, CSL Behring
• MICHAEL GLASER, Technology Innovation Director, GSK
• JAYLAXMI NALAWADE, Associate Director, Pharmacovigilance and REMS, Lupin
• KAL ELHOREGY, Director, Risk Evaluation and Mitigation Strategy (REMS) Programs, Amneal Pharmaceuticals
• MOHAMED ABDILLAHI, Director, Risk management Product Lead, Pfizer
• DIMITRIS ZAMPATIS, Scientific Director, Safety Strategy Lead, Healthcare Business of Merck
• TEODORA DOHERTY, Global Medical Safety (GMS), Medical Safety Officer, Janssen Research & Development
• JOHN SOLOMON, Head of Pharmacovigilance UK & Ireland, Sanofi
• SUMIT MUNJAL, Vice President, Global Patient Safety Evaluation, Takeda Pharmaceuticals
• TANJA PETERS, Head Global Patient Safety Neurology & Immunology, Merck KGaA
• AYSE BAKER, Vice President of Regulatory Affairs, Almatica (Alvogen)
• RAJ BHOGAL, Senior Director, R&D Audits & Inspections, Jazz Pharmaceuticals
• TEA BABIC, Director, PV Audits and Inspections, Teva Pharmaceuticals
• ISRAEL GUTIERREZ, VP Pharmacovigilance & Drug Safety, Geron Corporation
• OYINKANSOLA ODEBO, Assistant Director, Drug Safety Clinical Research, Supernus Pharmaceuticals
• DEEPA VENKATARAMAN, Head of Global Patient Safety and Pharmacovigilance, Summit Therapeutics
• KATARINA ILIC, Senior Clinical Pharmacology Medical Leader, Takeda Pharmaceuticals
• CHETAN SHATAPATHY, Consultant Medical Advisor, (QPPV) (Interim), Janssen Pharmaceutical
• KISHAN NANDHA, PVQA Manager & Lead Auditor, Astellas Pharmaceuticals
• EMMANUEL PHAM, Former Vice-President Biometry, IPSEN
• PAVAN BADALE, Head- PV Process Excellence, Safety case Management, Novartis
• ZULANE MALDONADO-CRUZ, Senior Drug Safety Specialist, Supernus Pharmaceuticals
• NICOLE BAKER, CEO, Biologit
• ARUN TIRUMALAI, Sr. Technical Consultant, GSK
• MARINA SUVAKOV, Global Head Safety Surveillance, Philip Morris
• DEEPA ARORA, Director, CLINEXEL Life Science
• SIVA KUMAR BUDDHA, Global Safety Physician Manager : Product Safety & Risk Management, Viatris
• JIM BUCHANAN, President, Covilance
• HEIDE CUNNING, US Pharmacovigilance Officer-Safety Services Operations, Janssen Pharmaceuticals
• PASQUALE FEDELE, R&D Director, Blu Pantheon
• BILL ARONSON, COO, Artificial Intelligence Research Group
• ADI BEN-ARI, Founder & CEO, Applied Blockchain
• KAVYA KADAM, Consultant Global Clinical Trials
FOCUSES ON:
• Market analysis – Pharmacovigilance in 2022 - future horizons and efficiencies
• Impacts of PV on Covid-19
• Regulations, Legal Implications for the pharmacovigilance Industry
• Outsourcing in Pharmacovigilance- Best Practices, Challenges and key consideration
• New Technologies in Pharmacovigilance (AI/ Machine Learning, IoT, Blockchain & Big Data)
• PV Audit & Inspections – Knowing what is to be done
• Never let a crisis go to waste: Practicing Pharmacovigilance Post-Pandemic!
• RWE & RWD
• PV – Risk Management and Planning - REMS
• Documentation (RMPs, PSURs, PADERs, PBRERs)
• Quality, Safety and Signal Detection - Future of 2020
• Medical devices – Increasing safety perspective
• Case studies from various countries on the PV frameworks around the world
• Patient centric approach to help improve patient safety
• The developing regulatory framework in advanced and developing markets – EU, USA & ROW
• Be part of a major networking opportunity
WHO SHOULD ATTEND:
CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:
Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the virtual exhibition area. Expand your knowledge of the latest business models and strategies in the high-level conference.


<< less

25th Pharmacovigilance 2021
“Latest developments in pharmacovigilance, drug safety & risk management”
22nd - 23rd September 2021, Virtual Conference (Time Zone - EST)
After the successful journey of a series of 24 Pharmacovigilance conferences, Virtue Insight is proud to announce its 25th more >>

This year’s conference will be held on Wednesday 29th and Thursday 30th of September 2021.

There will be a workshop on on 28th September, the day before the Conference starts.

Best Practices in the Field of Electronic Registry Design and Operation

Attendance at the workshop on the 28th September is free but by invitation only.

See a map of the conference locations here.

Car parking is available a short walk away from Robinson College, where the Conference will be held, at a cost of £10 per day and can be booked during the registration process. Nearby on-street parking may be used but it is usually hard to find.

Accommodation at Robinson College will be available. These are good quality, en-suite student rooms and cost £90 per night for bed and breakfast. These can be booked from 1st July here

Some good quality hotels in Cambridge are
The Graduate
Hilton Cambridge City Centre
Hotel du Vin
University Arms
The Clayton Hotel
The Fellowes House
<< less

This year’s conference will be held on Wednesday 29th and Thursday 30th of September 2021.

There will be a workshop on on 28th September, the day before the Conference starts.

Best Practices in the Field of Electronic Registry Design and Operation

Attendance at the workshop more >>

5th Pharma Pricing, Reimbursement & Market Access 2021
“Critical guide for successfully identifying your pricing, reimbursement and market access strategies”
28th - 29th September 2021, Virtual Conference (Time Zone - EST)
This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU.
DELEGATE REGISTRATION:
Email - kavitha@virtueinsight.co.in or TEL: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
EARLY BIRD PRICE (Valid Till 30th August 2021 - Not Valid for UK based attendees):
1 Delegate @ £399
3 Delegates @ £999
EARLY BIRD PRICE (Valid Till 30th August 2021 – For UK based attendees):
1 Delegate @ £399+VAT
3 Delegates @ £999+VAT
STANDARD PRICE (Valid From 31st August 2021 - Not Valid for UK based attendees)
1 Delegate @ £599
3 Delegates @ £1299
STANDARD PRICE (Valid From 31st August 2021 - For UK based attendees)
1 Delegate @ £599+VAT
3 Delegates @ £1299+VAT
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• BOXIONG TANG, Executive Director, Health Economics and Outcomes Research (HEOR), BeiGene
• MARTIN ROST, Senior Director, Market Access (Global), Pfizer
• JOLIE APICELLA, Assistant, U.S. Attorney’s Office, EDNY
• YONGHUA JING , Senior Director, Health Economics and Outcomes Research, Abbvie
• SHANTHY KRISHNARAJAH, Executive Director, Vifor Pharma
• GARY ELLEXSON, VP Corporate Accounts, Supernus Pharmaceuticals
• HEZEKIAH BLAKE, Director - Portfolio Planning and Market Insights, Ionis Pharmaceuticals
• RICHARD LINER , Senior Assistant General Counsel, Bayer
• ANGELINA IRIZARI-POLICARPIO, HEOR & Real World Evidence Leader of the U. S. Field Communications Team, Eisai
• GREG APOSTOL, Vice President & Head of Market Access, Alkermes
• SAMUEL MURPHY , CEO, Salubris Biotherapeutics
• LAURENE REDDING, Head, Value, Access & Policy, BeiGene
• MARTIJN NEGEN, VP Commercial Strategy, AM Pharma
• TIM HERMES, VP Market Access, Trade & Patient Services, Aurinia Pharmaceuticals
• ERIN MISTRY, SVP, Head of Payer Strategy, Gov’t Affairs & Trade, Cormedix
• ALEXANDER NATZ, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
• MALLORY O’CONNOR, Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
• MICHAEL THOMPSON , President & CEO, National Alliance of Healthcare Purchaser Coalitions
• ROBERT POPOVIAN , Chief Science Policy Officer, Global Healthy Living Foundation & Senior Health Policy Fellow, Progressive Policy Institute
• ELIZABETH JOHNSON, CEO, MedicoCX
• JOHN LINNELL, State Captain, COPD Foundation
• REED STEPHENS, Partner, Winston & Strawn
KEY THEMES:
• Formulating your best market access strategy during the pandemic
• US policy challenges for market access: Stepping ahead, especially during this Covid19
• How to capture and quantify patient value?
• Unrivalled opportunity to expose and address the market access challenges facing the industry
• The role of Real World Evidence (RWE) in Oncology
• Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
• Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
• Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
• How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
• Understanding - payers’ perspective
• Advocating and collaborating with payers for value in a new era
• Creating a robust patient services and reimbursement support program for biosimilar products
• Prioritising Patients! - Adding value through an innovative patient-centered approach
• Understand how price affects market access and learn on how to set prices for optimal access and returns.
• New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
• Evidence Generation - The strategic rigor and creativity applied to evidence generation
• Impact of social media and digital analytics
• Developing risk-sharing reimbursement models and value based pricing
• Patient engagement and adherence within the environment
• Explaining how to use the data sources and observational research for effective safety analysis
• Dwell ahead of regulatory developments & improving your strategies in a cost effective way Accelerating new medicine introduction in developing world & overcoming challenges
• Be part of a major networking opportunity
WHO SHOULD ATTEND:
Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of:
Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the virtual exhibition area. Expand your knowledge of the latest business models and strategies in the high-level conference.
<< less

5th Pharma Pricing, Reimbursement & Market Access 2021
“Critical guide for successfully identifying your pricing, reimbursement and market access strategies”
28th - 29th September 2021, Virtual Conference (Time Zone - EST)
This conference will provide an overview of global pricing, market access more >>

This year’s conference will be held on Wednesday 29th and Thursday 30th of September 2021. It will be held in Cambridge as an in-person conference, but also with the opportunity to join virtually for anyone who is not able to join in person.

This year the conference will focus on two topics. The first day will consist of reflections on the past, present and future of the Cape Town Convention in its first 20 years and the second day is an in-depth analysis of some key topics in relation to enforcement of international interests, particularly when the debtor is insolvent. Each session will include ample opportunity for questions and debate. The conference will be of interest both to academics and to practising lawyers.

Attendance at the workshops on the 28th September is by invitation only.

See a map of the conference locations here.

Car parking is available a short walk away from Robinson College at a cost of £10 per day and can be booked during the registration process. Nearby on-street parking may be found but it is scarce.

On-site accommodation at Robinson College will be available. These are good quality, en-suite student rooms and cost £90 per night for bed and breakfast. These can be booked from 1st July here

Some good quality hotels in Cambridge are
The Graduate
Hilton Cambridge City Centre
Hotel du Vin
University Arms
The Clayton Hotel
The Fellowes House
<< less

This year’s conference will be held on Wednesday 29th and Thursday 30th of September 2021. It will be held in Cambridge as an in-person conference, but also with the opportunity to join virtually for anyone who is not able to join in person.

This year the conference will focus on two topics. more >>

19th Global Recycling Expo proudly invitations participants throughout the globe to Global Recycling Expo all through October 04-05, 2021 in London, UK which incorporates set off keynote displays, Oral talks, Poster displays and Exhibitions. We are overjoyed to mention that it's miles the Global Recycling Expo with a purpose to be held in a lovely town of London, UK and therefore we invite you all to wait and register.

Global Recycling Expo is in particular primarily based totally on the Theme: “Don’t throw it away, it could be utilized in a few different ways’’. We warmly welcome all of the contributors of the World’s main Scientists, Researchers and Scholars to wait for the Convention. We offer a platform for younger Researchers and Students to give their studies thru oral Presentations thru which they could increase a basis for collaboration amongst younger researchers. << less

19th Global Recycling Expo proudly invitations participants throughout the globe to Global Recycling Expo all through October 04-05, 2021 in London, UK which incorporates set off keynote displays, Oral talks, Poster displays and Exhibitions. We are overjoyed to mention that it's miles the Global Recycling more >>

WELCOME TO DRUG DISCOVERY 2021 ELRIG’s annual Drug Discovery meeting is still Europe’s largest meeting for life sciences industry professionals and will return in the autumn of 2021, to celebrate the innovation and efforts of our industry and the scientific successes that we have shared throughout the period of the pandemic.

Drug Discovery 2021 promises to be a particularly special event, providing a platform for the whole drug discovery community to meet at a free to attend, in-person event, where members of ELRIG’s community may:

Re-connect with colleagues, as well as hear stories from scientists who have been responsible for combatting COVID-19 in the session tracks on infection and diagnostics.
Re-invent the process of drug discovery, by building diverse partnerships with even greater emphasis on efficiency, automation, and remote operation in our two session tracks of screening and chemistry.
Re-imagine and create a new vision for drug discovery, with insights from our innovation and disruptive strategies tracks.
2020 was a year of challenge, but it was also a turning point for our industry, as our community came together and was at the forefront of the scientific effort to overcome and manage the COVID virus. Together we made unprecedented scientific progress, which we will recognize and celebrate at Drug Discovery 2021.
<< less

WELCOME TO DRUG DISCOVERY 2021 ELRIG’s annual Drug Discovery meeting is still Europe’s largest meeting for life sciences industry professionals and will return in the autumn of 2021, to celebrate the innovation and efforts of our industry and the scientific successes that we have shared throughout the more >>

We are extremely gratified to declare our upcoming fortuitous neurology conference 4th World Congress on Neurology and Therapeutics Conference is scheduled during October 25-26, 2021 Vienna, Austria. Our propitious neurology congress is tailored around the theme “Know the Unknown Advanced Solutions on Neurology”. This conference is intended to bring forth enthralling concepts that will drive the field of neurology to the next standards. We aim to offer a chance to organize a workshop in addition to insightful presentations and discussions. The main goal of this event is to inspire and expose our participants to as much information as possible. For more information visit: https://neurology.pulsusconference.com/
Meta description:
Top neurology conferences with 1 million impressions worldwide best neurologists dignitaries under one roof World Congress on neurology therapeutics, scheduled during October 25-26, 2021 Vienna, Austria. For more information visit: https://neurology.pulsusconference.com/
<< less

We are extremely gratified to declare our upcoming fortuitous neurology conference 4th World Congress on Neurology and Therapeutics Conference is scheduled during October 25-26, 2021 Vienna, Austria. Our propitious neurology congress is tailored around the theme “Know the Unknown Advanced Solutions more >>

38th Global Nanotechnology Congress is scheduled to be held on November 01-02, 2021 at Rome, Italy. Our Organising Committee invites you to meet Your Objective Business sector With individuals from and around the globe concentrated on finding out about Nanotechnology and Materials Science, this is the best chance to achieve the biggest collection of members from everywhere throughout the World. Conduct shows, disperse data, meet with current, make a sprinkle with another product offering, and get name acknowledgment at this event. Widely acclaimed speakers, the latest methods, strategies, and the most up to date overhauls in nanotechnology are signs of this meeting.
Nanotechnology 2021 involves the tracks like Advanced Materials and practical Devices, Engineering Materials, Composite Materials, Magnetism & Multiferroism, Optical materials and plasmonics, Energy and gather Materials, Nanotechnology-Basics to applications, Nanopore science, Nanomedicine, Bio Nanotechnologies, Carbon nanostructures and graphene, Spintronics, Nanoparticle synthesis and applications
<< less

38th Global Nanotechnology Congress is scheduled to be held on November 01-02, 2021 at Rome, Italy. Our Organising Committee invites you to meet Your Objective Business sector With individuals from and around the globe concentrated on finding out about Nanotechnology and Materials Science, this is the more >>

ELRIG’s Discovery Technologies 2021: Early Drug Discovery Strategies

With the rapid advancement of new technologies the potential for developing life changing therapeutic interventions has never been so promising. With these possibilities new challenges arise, not least how to prosecute drug discovery campaigns against new and novel targets and those previously deemed intractable. This conference will explore evolving early drug discovery technologies to overcome these obstacles by focusing on three core themes:

Emerging Screening Strategies: will delve into a broad range of topics showcasing the innovative approaches being applied across early drug discovery endeavours. Areas for discussion will include CRISPR for target identification, the integration of AI, emerging screening paradigms and new therapeutic modalities amongst many others.

Mass Spectrometry & Biophysical Approaches in Early Drug Discovery: the application of direct detection MS techniques and biophysical approaches early in discovery is providing projects with rapid access to more reliable chemical equity faster. This session explores the implementation of these tools in a variety of applications including ASMS, covalent compound screening and cell-based MS.

Hit Triage: the success of Hit and Lead Discovery is defined by the quality of the equity they can identify whilst the pitfalls to waylay unsuspecting project teams are numerous. Many undesirable mechanisms exist to bloat hit outputs and obscure the starting points projects really need to focus on. This session will examine what the issues are and the strategies being adopted to deal with them.

This year’s Discovery Technologies is planned to take place face-to-face in the new and prestigious meeting facilities of Circle Square in central Manchester, UK. In addition to learning about the latest and most cutting-edge, science on early drug discovery strategies, there will be ample networking opportunities as well as an exhibition show-casing the technologies and their applications.
<< less

ELRIG’s Discovery Technologies 2021: Early Drug Discovery Strategies

With the rapid advancement of new technologies the potential for developing life changing therapeutic interventions has never been so promising. With these possibilities new challenges arise, not least how to prosecute drug more >>

The 19th World Congress on Clinical Pediatrics aims to present early in Pediatric research and clinical reports on etiologic, diagnosis and treatment and to address novel findings in Pediatrics & Child Health. The highlighted theme of our Conference is series “Current Evolution of Latest Theories and Therapies to Save a Child”. Conference series LLC Ltd is pleased to announce that the 2021 Clinical Pediatrics conferences will be held in the beautiful city of Vienna, Austria. << less

The 19th World Congress on Clinical Pediatrics aims to present early in Pediatric research and clinical reports on etiologic, diagnosis and treatment and to address novel findings in Pediatrics & Child Health. The highlighted theme of our Conference is series “Current Evolution of Latest Theories and more >>

The 7th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems and pre-clinical and clinical biomarkers. Since our first meeting in 2008, we have seen the technology develop and the applications widen across many areas of industrial and academic drug discovery and development.

This meeting will focus on the application of Flow Cytometry and Imaging to illuminate biology from the single cell to the patient. The scientific program for this meeting is:

Translational Flow Cytometry and Imaging in Drug Discovery and Development: Application of technology in biological models from the microscale and single cell through to complex in-vitro tissue systems and the clinic.
Novel and Emerging Technologies: Next generation instrumentation, and probe and sensor technology for pharmaceutical research.
Drug discovery in the era of Multi-omics and spatial cytometry: Exploration of the latest multi-parameter techniques and the analytical challenges of using multi-omics approaches to link the genome and proteome to cellular regulation and function.
We aim to bring together the research community working in the field of flow cytometry and imaging with interests in developing and applying the technology for pharmaceutical research. Join scientists from pharma, biotech, CROs and academia to hear talks given by speakers at the cutting edge of cytometry, network at the exhibition, innovation forum and speakers dinner and gain strategic insights into solutions for increasing the success of drug discovery and development. << less

The 7th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems and pre-clinical and clinical biomarkers. Since more >>

Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best amassing of people from the mending focuses, Universities, Heart Associations, and so forth...

https://www.heart.scientexconference.com/

E: heart@scientexevents.com

heart@scientexconferences.com

Scientific Highlights
• Heart Disease & Failure

• Heart Diagnosis

• Cardiac and Cardiovascular Research

• Heart Devices

• Diabetes, Obesity & Stroke

• Interventional Cardiology

• Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology

• Pediatric Cardiology & Women’s Cardiology

• Cardiac Nursing

• Heart Regeneration

• Cardiac Pharmacology, Cardiac Surgery

• Cardiac Diet/Cardiac Nutrition

• Cardiovascular Impact of COVID-19

• Case Reports on Cardiology

• Cardiology - Future Medicine
<< less

Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding more >>

Scientex conference gladly welcomes each and every ambitious participant across different disciplines to take part in our International Conference on Biomaterials and Biomedical Engineering which will be held on April 18-19, 2022 at Dubai, United Arab Emirates under the theme of "Applications of Leading Trends in the field of Biomaterials and Biomedical Engineering".

The conference will share lessons from the keynote speakers who have blazed trails in the field of biomaterials and biomedical engineering as well as bring together a multi-disciplinary group of elite thinkers who are connected through a shared interest in biomedical engineering. The conference will feature sessions on the applications, methodologies, the current status, future prospects in the context of material science and allows the attendees to share their research and helps them connect with co-participants, professionals and peers.
<< less

Scientex conference gladly welcomes each and every ambitious participant across different disciplines to take part in our International Conference on Biomaterials and Biomedical Engineering which will be held on April 18-19, 2022 at Dubai, United Arab Emirates under the theme of "Applications of Leading more >>